Pfizer Inc.

NYSE:PFE  
51.62
+1.53 (+3.06%)
4:02:09 PM EDT: $51.46 -0.16 (-0.31%)
Products

Myovant Sciences And Pfizer Announce FDA Acceptance Of Supplemental New Drug Application For Myfembree

Published: 06/02/2022 10:59 GMT
Pfizer Inc. (PFE) - Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for Myfembree®.
Myovant Sciences Ltd - FDA Set a Target Action Date of January 29, 2023 for This Snda Under Prescription Drug User Fee Act.